Gene Symbol | Gene ID | Gene Info |
---|---|---|
Mef2d
|
ENSMUSG00000001419.11 | myocyte enhancer factor 2D |
Mef2a
|
ENSMUSG00000030557.10 | myocyte enhancer factor 2A |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr7_67380454_67380605 | Mef2a | 7671 | 0.193206 | 0.42 | 7.3e-04 | Click! |
chr7_67372985_67373475 | Mef2a | 372 | 0.846359 | -0.26 | 4.4e-02 | Click! |
chr7_67265920_67266071 | Mef2a | 167 | 0.944922 | 0.12 | 3.6e-01 | Click! |
chr7_67324871_67325022 | Mef2a | 7981 | 0.201401 | 0.11 | 4.2e-01 | Click! |
chr7_67371750_67372792 | Mef2a | 556 | 0.674351 | 0.11 | 4.2e-01 | Click! |
chr3_88149192_88151055 | Mef2d | 7549 | 0.103014 | 0.71 | 1.6e-10 | Click! |
chr3_88133416_88134202 | Mef2d | 8563 | 0.105656 | 0.69 | 1.3e-09 | Click! |
chr3_88144787_88144938 | Mef2d | 2288 | 0.170582 | 0.62 | 1.1e-07 | Click! |
chr3_88144026_88144230 | Mef2d | 1554 | 0.240239 | 0.60 | 5.1e-07 | Click! |
chr3_88144311_88144462 | Mef2d | 1812 | 0.207680 | 0.57 | 2.1e-06 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr7_128205575_128206445 | 10.33 |
Cox6a2 |
cytochrome c oxidase subunit 6A2 |
377 |
0.67 |
chr10_33083961_33084356 | 8.94 |
Trdn |
triadin |
597 |
0.81 |
chr8_48511120_48511677 | 7.65 |
Tenm3 |
teneurin transmembrane protein 3 |
43915 |
0.19 |
chr10_3368375_3368998 | 7.13 |
Ppp1r14c |
protein phosphatase 1, regulatory inhibitor subunit 14C |
2142 |
0.36 |
chr9_85090484_85090658 | 6.89 |
Gm28070 |
predicted gene 28070 |
14194 |
0.25 |
chr7_19411651_19412289 | 6.89 |
Ckm |
creatine kinase, muscle |
907 |
0.3 |
chrX_95477898_95478308 | 6.63 |
Asb12 |
ankyrin repeat and SOCS box-containing 12 |
26 |
0.98 |
chr16_85268964_85269179 | 6.07 |
App |
amyloid beta (A4) precursor protein |
95305 |
0.07 |
chr18_4995747_4996610 | 6.00 |
Svil |
supervillin |
1242 |
0.62 |
chr13_113662906_113663717 | 5.97 |
Hspb3 |
heat shock protein 3 |
365 |
0.85 |
chr5_113137394_113137718 | 5.71 |
2900026A02Rik |
RIKEN cDNA 2900026A02 gene |
430 |
0.72 |
chr11_77800451_77802048 | 5.54 |
Myo18a |
myosin XVIIIA |
49 |
0.97 |
chr1_75374828_75376320 | 5.24 |
Speg |
SPEG complex locus |
277 |
0.67 |
chr17_81737002_81738450 | 5.22 |
Slc8a1 |
solute carrier family 8 (sodium/calcium exchanger), member 1 |
651 |
0.81 |
chr2_140202844_140203194 | 5.20 |
Ndufaf5 |
NADH:ubiquinone oxidoreductase complex assembly factor 5 |
31989 |
0.15 |
chr11_40754069_40754308 | 5.02 |
Ccng1 |
cyclin G1 |
250 |
0.92 |
chr2_155611238_155612364 | 4.99 |
Myh7b |
myosin, heavy chain 7B, cardiac muscle, beta |
589 |
0.53 |
chr14_55575537_55576846 | 4.87 |
Gm15932 |
predicted gene 15932 |
200 |
0.69 |
chr17_71019478_71020561 | 4.70 |
Myom1 |
myomesin 1 |
428 |
0.76 |
chr12_34527603_34529023 | 4.51 |
Hdac9 |
histone deacetylase 9 |
9 |
0.99 |
chr4_46040285_46040964 | 4.49 |
Tmod1 |
tropomodulin 1 |
1415 |
0.43 |
chr2_76805862_76806506 | 4.46 |
Ttn |
titin |
20358 |
0.22 |
chr3_155055105_155055726 | 4.42 |
Tnni3k |
TNNI3 interacting kinase |
8 |
0.98 |
chr9_101198368_101199080 | 4.38 |
Ppp2r3a |
protein phosphatase 2, regulatory subunit B'', alpha |
127 |
0.94 |
chr1_83345575_83345998 | 4.37 |
Gm37517 |
predicted gene, 37517 |
13200 |
0.18 |
chr12_86360988_86362126 | 4.34 |
Esrrb |
estrogen related receptor, beta |
440 |
0.84 |
chr16_4522019_4522667 | 4.32 |
Srl |
sarcalumenin |
720 |
0.62 |
chr4_140580764_140581885 | 4.15 |
Arhgef10l |
Rho guanine nucleotide exchange factor (GEF) 10-like |
478 |
0.83 |
chr6_147506132_147507107 | 4.07 |
4933406L23Rik |
RIKEN cDNA 4933406L23 gene |
24690 |
0.17 |
chrX_59585692_59586195 | 3.98 |
Fgf13 |
fibroblast growth factor 13 |
17872 |
0.27 |
chr1_176124274_176124802 | 3.90 |
Gm37916 |
predicted gene, 37916 |
54663 |
0.12 |
chr3_60576768_60577034 | 3.85 |
Mbnl1 |
muscleblind like splicing factor 1 |
18740 |
0.19 |
chr19_50374825_50375211 | 3.80 |
Sorcs1 |
sortilin-related VPS10 domain containing receptor 1 |
122340 |
0.06 |
chr9_91152091_91152262 | 3.79 |
Gm36960 |
predicted gene, 36960 |
21658 |
0.18 |
chr13_44228598_44229389 | 3.75 |
Gm47781 |
predicted gene, 47781 |
3405 |
0.22 |
chr5_23251641_23252335 | 3.75 |
Gm28022 |
predicted gene, 28022 |
27923 |
0.16 |
chr11_102217551_102219283 | 3.71 |
Hdac5 |
histone deacetylase 5 |
511 |
0.62 |
chr3_152262616_152262926 | 3.62 |
Nexn |
nexilin |
241 |
0.89 |
chr1_21829558_21830565 | 3.62 |
Gm38243 |
predicted gene, 38243 |
10453 |
0.24 |
chr6_116072470_116073176 | 3.61 |
Tmcc1 |
transmembrane and coiled coil domains 1 |
333 |
0.88 |
chr12_107930390_107931544 | 3.53 |
Bcl11b |
B cell leukemia/lymphoma 11B |
72447 |
0.11 |
chr2_107306085_107306387 | 3.52 |
Kcna4 |
potassium voltage-gated channel, shaker-related subfamily, member 4 |
14841 |
0.29 |
chr2_94122572_94123070 | 3.51 |
Hsd17b12 |
hydroxysteroid (17-beta) dehydrogenase 12 |
35072 |
0.14 |
chr2_79511072_79511365 | 3.45 |
Cerkl |
ceramide kinase-like |
54433 |
0.13 |
chr13_5897795_5898006 | 3.40 |
Gm47507 |
predicted gene, 47507 |
10791 |
0.16 |
chr13_109686854_109687251 | 3.38 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
876 |
0.76 |
chr16_46488994_46489238 | 3.37 |
Nectin3 |
nectin cell adhesion molecule 3 |
7656 |
0.28 |
chr10_13974281_13974896 | 3.35 |
Hivep2 |
human immunodeficiency virus type I enhancer binding protein 2 |
7564 |
0.2 |
chr10_68842041_68842750 | 3.27 |
1700048P04Rik |
RIKEN cDNA 1700048P04 gene |
62105 |
0.13 |
chr1_43159364_43159948 | 3.25 |
Fhl2 |
four and a half LIM domains 2 |
4305 |
0.2 |
chr7_115706067_115706318 | 3.19 |
Sox6 |
SRY (sex determining region Y)-box 6 |
43827 |
0.2 |
chr17_79451074_79451933 | 3.18 |
Cdc42ep3 |
CDC42 effector protein (Rho GTPase binding) 3 |
96412 |
0.07 |
chr9_110765100_110765787 | 3.18 |
Myl3 |
myosin, light polypeptide 3 |
418 |
0.74 |
chr2_163363092_163363405 | 3.15 |
Jph2 |
junctophilin 2 |
34701 |
0.11 |
chr9_71589501_71589754 | 3.11 |
Myzap |
myocardial zonula adherens protein |
2638 |
0.27 |
chr15_61599807_61600090 | 3.10 |
Gm49498 |
predicted gene, 49498 |
55765 |
0.16 |
chr9_68711162_68711357 | 3.10 |
Rora |
RAR-related orphan receptor alpha |
55956 |
0.16 |
chr11_102816428_102816877 | 3.04 |
Gjc1 |
gap junction protein, gamma 1 |
2527 |
0.16 |
chr5_75975002_75975424 | 3.02 |
Kdr |
kinase insert domain protein receptor |
3245 |
0.23 |
chr15_58770093_58770373 | 2.99 |
Gm20712 |
predicted gene 20712 |
11718 |
0.18 |
chr1_131232374_131233673 | 2.90 |
Rassf5 |
Ras association (RalGDS/AF-6) domain family member 5 |
552 |
0.67 |
chr8_46236509_46237067 | 2.89 |
Gm23812 |
predicted gene, 23812 |
6994 |
0.1 |
chr9_67670151_67670404 | 2.88 |
Gm47110 |
predicted gene, 47110 |
29904 |
0.15 |
chr9_107596489_107597170 | 2.86 |
Lsmem2 |
leucine-rich single-pass membrane protein 2 |
246 |
0.73 |
chr12_24963377_24963763 | 2.83 |
Kidins220 |
kinase D-interacting substrate 220 |
11355 |
0.18 |
chr1_178486812_178487110 | 2.81 |
Efcab2 |
EF-hand calcium binding domain 2 |
38177 |
0.14 |
chr10_69529318_69529556 | 2.80 |
Ank3 |
ankyrin 3, epithelial |
4335 |
0.28 |
chr9_24766430_24766801 | 2.78 |
Tbx20 |
T-box 20 |
3065 |
0.25 |
chr18_11069230_11069546 | 2.77 |
Gata6 |
GATA binding protein 6 |
10341 |
0.23 |
chr5_51412320_51412698 | 2.74 |
Gm42614 |
predicted gene 42614 |
71796 |
0.1 |
chr7_38224544_38225145 | 2.74 |
Plekhf1 |
pleckstrin homology domain containing, family F (with FYVE domain) member 1 |
3172 |
0.18 |
chr9_67428325_67429235 | 2.72 |
Tln2 |
talin 2 |
23 |
0.98 |
chr6_70887688_70888468 | 2.70 |
Gm43292 |
predicted gene 43292 |
2276 |
0.23 |
chr13_43536578_43536991 | 2.66 |
Gm32939 |
predicted gene, 32939 |
6564 |
0.15 |
chr9_21803943_21804542 | 2.62 |
Dock6 |
dedicator of cytokinesis 6 |
241 |
0.86 |
chr15_93698224_93698894 | 2.60 |
Gm41386 |
predicted gene, 41386 |
14210 |
0.19 |
chr9_31997751_31998085 | 2.56 |
Gm47465 |
predicted gene, 47465 |
7542 |
0.17 |
chr3_130979175_130979410 | 2.54 |
2010110G14Rik |
RIKEN cDNA 2010110G14 gene |
41955 |
0.1 |
chr9_99682029_99682717 | 2.54 |
Gm16004 |
predicted gene 16004 |
26026 |
0.13 |
chr10_123360436_123360805 | 2.52 |
Gm22958 |
predicted gene, 22958 |
71946 |
0.1 |
chr12_73846939_73847247 | 2.51 |
Gm15283 |
predicted gene 15283 |
22519 |
0.15 |
chr2_35259398_35260132 | 2.50 |
Gsn |
gelsolin |
3316 |
0.19 |
chr12_99306022_99306479 | 2.47 |
Gm20682 |
predicted gene 20682 |
9630 |
0.15 |
chr5_112896071_112896320 | 2.44 |
Myo18b |
myosin XVIIIb |
167 |
0.96 |
chr8_57333046_57334560 | 2.43 |
Gm34030 |
predicted gene, 34030 |
584 |
0.59 |
chr5_31570347_31571797 | 2.41 |
AI839979 |
expressed sequence AI839979 |
319 |
0.77 |
chr11_120647315_120648501 | 2.40 |
Myadml2 |
myeloid-associated differentiation marker-like 2 |
202 |
0.49 |
chr4_135269698_135270041 | 2.40 |
Clic4 |
chloride intracellular channel 4 (mitochondrial) |
2945 |
0.19 |
chr11_89056352_89056596 | 2.38 |
Dgke |
diacylglycerol kinase, epsilon |
4274 |
0.14 |
chr6_35002418_35002740 | 2.38 |
Slc23a4 |
solute carrier family 23 member 4 |
14175 |
0.18 |
chr12_34517205_34517468 | 2.37 |
Hdac9 |
histone deacetylase 9 |
10968 |
0.3 |
chr15_25940423_25941291 | 2.36 |
Retreg1 |
reticulophagy regulator 1 |
30 |
0.98 |
chr6_117574138_117574475 | 2.35 |
Gm9946 |
predicted gene 9946 |
6634 |
0.22 |
chr14_41017251_41018058 | 2.35 |
Prxl2a |
peroxiredoxin like 2A |
3866 |
0.19 |
chr7_69891593_69891960 | 2.34 |
Gm44690 |
predicted gene 44690 |
7416 |
0.25 |
chr5_148026696_148027441 | 2.34 |
Mtus2 |
microtubule associated tumor suppressor candidate 2 |
55820 |
0.12 |
chr5_51566574_51566861 | 2.33 |
Ppargc1a |
peroxisome proliferative activated receptor, gamma, coactivator 1 alpha |
987 |
0.6 |
chr2_70315209_70315360 | 2.33 |
Rpl9-ps7 |
ribosomal protein L9, pseudogene 7 |
143698 |
0.04 |
chr1_34326350_34326979 | 2.29 |
Gm37958 |
predicted gene, 37958 |
3643 |
0.16 |
chr8_89726516_89726753 | 2.28 |
Gm24212 |
predicted gene, 24212 |
59330 |
0.16 |
chr11_84344771_84345226 | 2.27 |
Acaca |
acetyl-Coenzyme A carboxylase alpha |
64543 |
0.11 |
chr3_154467770_154468223 | 2.26 |
Tyw3 |
tRNA-yW synthesizing protein 3 homolog (S. cerevisiae) |
126538 |
0.05 |
chr10_58394969_58395625 | 2.25 |
Lims1 |
LIM and senescent cell antigen-like domains 1 |
909 |
0.6 |
chr3_123115774_123116765 | 2.24 |
Synpo2 |
synaptopodin 2 |
783 |
0.59 |
chr12_107131932_107132083 | 2.22 |
Gm16085 |
predicted gene 16085 |
2326 |
0.29 |
chr19_53276772_53277296 | 2.21 |
Gm36339 |
predicted gene, 36339 |
10403 |
0.14 |
chr11_89804459_89805123 | 2.20 |
Ankfn1 |
ankyrin-repeat and fibronectin type III domain containing 1 |
27138 |
0.25 |
chr4_34781708_34782043 | 2.20 |
Smim8 |
small integral membrane protein 8 |
3452 |
0.21 |
chr6_136856791_136856995 | 2.20 |
Art4 |
ADP-ribosyltransferase 4 |
840 |
0.41 |
chr17_48430526_48430734 | 2.19 |
Apobec2 |
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 2 |
1988 |
0.21 |
chr10_37988715_37989307 | 2.17 |
Gm24710 |
predicted gene, 24710 |
57331 |
0.15 |
chr11_105495482_105496208 | 2.17 |
Marchf10 |
membrane associated ring-CH-type finger 10 |
39110 |
0.15 |
chr15_58974614_58974812 | 2.16 |
Mtss1 |
MTSS I-BAR domain containing 1 |
2174 |
0.26 |
chr16_22564404_22564629 | 2.16 |
Gm15651 |
predicted gene 15651 |
15963 |
0.11 |
chr18_77742321_77742943 | 2.16 |
A330094K24Rik |
RIKEN cDNA A330094K24 gene |
9893 |
0.13 |
chr6_35362432_35362876 | 2.16 |
1700065J11Rik |
RIKEN cDNA 1700065J11 gene |
31808 |
0.15 |
chr3_137341050_137342448 | 2.15 |
Emcn |
endomucin |
575 |
0.82 |
chr16_18229406_18230609 | 2.15 |
Zdhhc8 |
zinc finger, DHHC domain containing 8 |
5129 |
0.08 |
chr16_52071876_52072313 | 2.13 |
Cblb |
Casitas B-lineage lymphoma b |
22441 |
0.21 |
chr13_12033129_12034063 | 2.13 |
Gm47493 |
predicted gene, 47493 |
18459 |
0.21 |
chr17_63317765_63318290 | 2.11 |
4930405O22Rik |
RIKEN cDNA 4930405O22 gene |
5054 |
0.23 |
chr11_77876086_77876330 | 2.09 |
Pipox |
pipecolic acid oxidase |
6478 |
0.15 |
chr8_48380171_48380442 | 2.09 |
Tenm3 |
teneurin transmembrane protein 3 |
80207 |
0.1 |
chr6_85371815_85372854 | 2.07 |
Rab11fip5 |
RAB11 family interacting protein 5 (class I) |
2230 |
0.24 |
chr6_55132964_55133311 | 2.07 |
Crhr2 |
corticotropin releasing hormone receptor 2 |
121 |
0.96 |
chr16_94765290_94765719 | 2.06 |
Gm41505 |
predicted gene, 41505 |
43610 |
0.14 |
chr2_77312672_77312965 | 2.05 |
Gm13943 |
predicted gene 13943 |
1933 |
0.29 |
chr8_118476958_118477255 | 2.04 |
Gm24035 |
predicted gene, 24035 |
50507 |
0.16 |
chr13_113657225_113657681 | 2.03 |
Hspb3 |
heat shock protein 3 |
6223 |
0.18 |
chr14_32683140_32683919 | 2.03 |
3425401B19Rik |
RIKEN cDNA 3425401B19 gene |
1743 |
0.31 |
chr10_69944857_69945228 | 2.02 |
Ank3 |
ankyrin 3, epithelial |
18909 |
0.27 |
chr3_97651242_97651966 | 2.02 |
Prkab2 |
protein kinase, AMP-activated, beta 2 non-catalytic subunit |
6589 |
0.14 |
chr8_27269032_27269227 | 2.00 |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
4715 |
0.13 |
chr13_88828286_88828886 | 2.00 |
Edil3 |
EGF-like repeats and discoidin I-like domains 3 |
6944 |
0.33 |
chr9_105520039_105521535 | 2.00 |
Atp2c1 |
ATPase, Ca++-sequestering |
360 |
0.86 |
chr14_120532521_120532792 | 2.00 |
Rap2a |
RAS related protein 2a |
54212 |
0.14 |
chr4_120810788_120810939 | 2.00 |
Nfyc |
nuclear transcription factor-Y gamma |
4849 |
0.14 |
chr15_53400049_53400480 | 2.00 |
Gm27926 |
predicted gene, 27926 |
16345 |
0.26 |
chr9_98568029_98568276 | 2.00 |
Copb2 |
coatomer protein complex, subunit beta 2 (beta prime) |
4421 |
0.14 |
chr14_63247276_63249044 | 1.99 |
Gata4 |
GATA binding protein 4 |
2889 |
0.24 |
chr5_29363493_29363769 | 1.99 |
Lmbr1 |
limb region 1 |
2541 |
0.25 |
chr17_70997929_70998765 | 1.98 |
Myl12a |
myosin, light chain 12A, regulatory, non-sarcomeric |
216 |
0.88 |
chr8_79095332_79095764 | 1.97 |
Zfp827 |
zinc finger protein 827 |
22779 |
0.21 |
chr11_31874060_31874636 | 1.97 |
Cpeb4 |
cytoplasmic polyadenylation element binding protein 4 |
1073 |
0.55 |
chr16_89830219_89830776 | 1.97 |
Tiam1 |
T cell lymphoma invasion and metastasis 1 |
7378 |
0.3 |
chr2_90964960_90965890 | 1.95 |
Celf1 |
CUGBP, Elav-like family member 1 |
333 |
0.83 |
chr13_56118247_56118633 | 1.94 |
Macroh2a1 |
macroH2A.1 histone |
16385 |
0.17 |
chr7_90146526_90146712 | 1.94 |
Gm45222 |
predicted gene 45222 |
671 |
0.57 |
chr5_122499512_122499696 | 1.92 |
Atp2a2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
2013 |
0.17 |
chr10_27990416_27990645 | 1.91 |
Gm10145 |
predicted gene 10145 |
54166 |
0.13 |
chr13_103097993_103098207 | 1.91 |
Mast4 |
microtubule associated serine/threonine kinase family member 4 |
1255 |
0.59 |
chr7_82425238_82425812 | 1.90 |
Adamtsl3 |
ADAMTS-like 3 |
17051 |
0.23 |
chr2_131514161_131514436 | 1.90 |
Smox |
spermine oxidase |
5346 |
0.19 |
chr10_68168190_68168448 | 1.90 |
Arid5b |
AT rich interactive domain 5B (MRF1-like) |
31693 |
0.21 |
chr14_48589666_48590768 | 1.90 |
Gm49120 |
predicted gene, 49120 |
382 |
0.79 |
chr17_72920336_72921423 | 1.88 |
Lbh |
limb-bud and heart |
309 |
0.93 |
chr11_101790699_101791513 | 1.87 |
Etv4 |
ets variant 4 |
5735 |
0.17 |
chr10_58354534_58355136 | 1.87 |
Gm23058 |
predicted gene, 23058 |
5231 |
0.2 |
chr17_70528895_70529144 | 1.87 |
Dlgap1 |
DLG associated protein 1 |
6857 |
0.31 |
chr3_136007264_136008202 | 1.86 |
Gm5281 |
predicted gene 5281 |
43955 |
0.12 |
chr12_112618378_112619191 | 1.86 |
Adssl1 |
adenylosuccinate synthetase like 1 |
1261 |
0.33 |
chr13_12339135_12341134 | 1.85 |
Actn2 |
actinin alpha 2 |
590 |
0.73 |
chr15_66559076_66559686 | 1.85 |
Tmem71 |
transmembrane protein 71 |
1722 |
0.39 |
chr13_113013114_113013713 | 1.84 |
Mcidas |
multiciliate differentiation and DNA synthesis associated cell cycle protein |
19568 |
0.08 |
chr19_57157601_57157981 | 1.84 |
Ablim1 |
actin-binding LIM protein 1 |
22066 |
0.23 |
chr5_17831796_17831947 | 1.83 |
Cd36 |
CD36 molecule |
3825 |
0.36 |
chr3_8635449_8635667 | 1.82 |
Gm32496 |
predicted gene, 32496 |
7507 |
0.15 |
chr1_82200135_82200286 | 1.82 |
Gm9747 |
predicted gene 9747 |
32902 |
0.17 |
chr17_40878873_40879024 | 1.81 |
9130008F23Rik |
RIKEN cDNA 9130008F23 gene |
1610 |
0.29 |
chr15_41076262_41076625 | 1.80 |
Gm49524 |
predicted gene, 49524 |
78483 |
0.1 |
chr15_37733930_37734441 | 1.80 |
Gm49397 |
predicted gene, 49397 |
150 |
0.54 |
chr3_68676477_68677404 | 1.80 |
Il12a |
interleukin 12a |
13704 |
0.19 |
chr2_70848531_70848682 | 1.79 |
Gm13633 |
predicted gene 13633 |
8083 |
0.19 |
chr5_119359665_119359968 | 1.79 |
n-R5s175 |
nuclear encoded rRNA 5S 175 |
62571 |
0.13 |
chr15_55897322_55897847 | 1.79 |
Sntb1 |
syntrophin, basic 1 |
8726 |
0.18 |
chr1_90753967_90754699 | 1.78 |
Col6a3 |
collagen, type VI, alpha 3 |
18882 |
0.21 |
chr19_27581480_27582292 | 1.76 |
Gm50101 |
predicted gene, 50101 |
69378 |
0.12 |
chr17_71027174_71027345 | 1.75 |
Myom1 |
myomesin 1 |
7668 |
0.13 |
chr3_95961392_95961684 | 1.75 |
Gm20940 |
predicted gene, 20940 |
2850 |
0.14 |
chr1_155526845_155527426 | 1.75 |
Gm5532 |
predicted gene 5532 |
8 |
0.98 |
chr19_56726523_56727969 | 1.75 |
Adrb1 |
adrenergic receptor, beta 1 |
3383 |
0.2 |
chr9_24763396_24763680 | 1.74 |
Tbx20 |
T-box 20 |
6142 |
0.2 |
chr2_166605076_166605640 | 1.74 |
Prex1 |
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1 |
2271 |
0.35 |
chr8_119670488_119671282 | 1.73 |
Gm32352 |
predicted gene, 32352 |
4 |
0.96 |
chr11_7056096_7056584 | 1.72 |
Adcy1 |
adenylate cyclase 1 |
7149 |
0.27 |
chr17_10311671_10311978 | 1.72 |
Qk |
quaking |
7537 |
0.24 |
chr5_32272493_32272765 | 1.72 |
Plb1 |
phospholipase B1 |
25278 |
0.15 |
chr3_119794957_119795196 | 1.71 |
Ptbp2 |
polypyrimidine tract binding protein 2 |
10610 |
0.16 |
chr16_37550527_37550810 | 1.70 |
Gm49569 |
predicted gene, 49569 |
1499 |
0.33 |
chr2_31191797_31192069 | 1.70 |
Gm22516 |
predicted gene, 22516 |
2242 |
0.22 |
chr1_106181097_106181567 | 1.70 |
Phlpp1 |
PH domain and leucine rich repeat protein phosphatase 1 |
9580 |
0.18 |
chr19_24046811_24047201 | 1.70 |
Fam189a2 |
family with sequence similarity 189, member A2 |
15987 |
0.16 |
chr13_112425457_112425830 | 1.69 |
Gm48876 |
predicted gene, 48876 |
697 |
0.61 |
chr9_35564707_35565318 | 1.69 |
Hyls1 |
HYLS1, centriolar and ciliogenesis associated |
5085 |
0.1 |
chr8_18738571_18739759 | 1.68 |
Angpt2 |
angiopoietin 2 |
2397 |
0.3 |
chr4_31456787_31456952 | 1.67 |
Gm11922 |
predicted gene 11922 |
76397 |
0.13 |
chr9_52281045_52281314 | 1.67 |
Gm25562 |
predicted gene, 25562 |
10020 |
0.23 |
chr7_125933387_125933600 | 1.67 |
D430042O09Rik |
RIKEN cDNA D430042O09 gene |
68222 |
0.11 |
chr9_119574118_119574458 | 1.66 |
Scn5a |
sodium channel, voltage-gated, type V, alpha |
4728 |
0.26 |
chr8_44165165_44165393 | 1.64 |
Gm37972 |
predicted gene, 37972 |
63266 |
0.13 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 8.3 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
1.6 | 4.8 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
1.4 | 7.1 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
1.4 | 4.2 | GO:0007525 | somatic muscle development(GO:0007525) |
1.2 | 3.5 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
1.1 | 2.2 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
1.0 | 3.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.9 | 2.7 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.9 | 6.1 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.7 | 5.0 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.7 | 5.5 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.7 | 3.4 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.7 | 2.0 | GO:0030421 | defecation(GO:0030421) |
0.6 | 6.3 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.6 | 2.4 | GO:0030035 | microspike assembly(GO:0030035) |
0.6 | 1.8 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.5 | 3.0 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.4 | 1.3 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.4 | 2.2 | GO:0003175 | tricuspid valve development(GO:0003175) |
0.4 | 1.3 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.4 | 2.4 | GO:1990000 | amyloid fibril formation(GO:1990000) |
0.4 | 1.2 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.4 | 1.5 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.4 | 0.4 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.4 | 1.1 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.4 | 1.4 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.3 | 1.0 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.3 | 1.0 | GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
0.3 | 0.7 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.3 | 1.0 | GO:1902996 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
0.3 | 0.6 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
0.3 | 2.0 | GO:0097264 | self proteolysis(GO:0097264) |
0.3 | 0.6 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.3 | 0.8 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
0.3 | 0.8 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.3 | 3.8 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.2 | 1.0 | GO:2000065 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.2 | 0.7 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.2 | 1.6 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.2 | 0.2 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
0.2 | 0.5 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.2 | 0.2 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.2 | 0.9 | GO:0060486 | Clara cell differentiation(GO:0060486) |
0.2 | 2.2 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.2 | 1.1 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 1.1 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.2 | 2.3 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
0.2 | 0.6 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.2 | 0.2 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.2 | 0.6 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.2 | 2.9 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.2 | 0.5 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.2 | 0.4 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
0.2 | 1.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.2 | 0.5 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.2 | 0.7 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.2 | 0.6 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.2 | 1.4 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.2 | 0.3 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.2 | 1.1 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.2 | 0.3 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.2 | 2.8 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.2 | 0.3 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.1 | 0.9 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.1 | 0.6 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.1 | 0.4 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.1 | 0.4 | GO:0072338 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.1 | 0.4 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.1 | 1.0 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.1 | 0.4 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.1 | 0.4 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.1 | 0.6 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.1 | 0.1 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.1 | 0.5 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 3.1 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 0.4 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.1 | 0.5 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.1 | 0.3 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.1 | 0.3 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.1 | 0.5 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.1 | 0.5 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.1 | 0.9 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.1 | 0.6 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 0.5 | GO:0086013 | membrane repolarization during cardiac muscle cell action potential(GO:0086013) |
0.1 | 0.4 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.1 | 0.4 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.1 | 0.4 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.1 | 0.5 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.1 | 0.2 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.1 | 0.4 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.1 | 0.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.1 | 0.2 | GO:0010159 | specification of organ position(GO:0010159) |
0.1 | 0.7 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.1 | 0.3 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.1 | 0.6 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 1.0 | GO:0034331 | cell junction maintenance(GO:0034331) |
0.1 | 0.6 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.1 | 0.3 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.1 | 0.1 | GO:1902548 | negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.1 | 0.3 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.1 | 0.2 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.1 | 0.2 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.1 | 0.3 | GO:0032439 | endosome localization(GO:0032439) |
0.1 | 0.6 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.1 | 1.7 | GO:0006828 | manganese ion transport(GO:0006828) |
0.1 | 0.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.1 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
0.1 | 0.5 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.1 | 0.2 | GO:0061419 | positive regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061419) |
0.1 | 0.2 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 0.1 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.1 | 0.2 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.1 | 0.7 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.1 | 0.8 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.5 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 0.2 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.1 | 0.4 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.1 | 0.4 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.1 | 0.4 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.1 | 0.3 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.1 | 0.3 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.1 | 0.5 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.1 | 0.4 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 0.1 | GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.1 | 0.3 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.1 | 0.8 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.1 | 0.2 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.1 | 0.3 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.1 | 0.3 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.1 | 0.3 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.1 | 0.1 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.1 | 0.2 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.1 | 0.2 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.1 | 0.2 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.1 | 0.2 | GO:0086005 | ventricular cardiac muscle cell action potential(GO:0086005) |
0.1 | 0.1 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.1 | 0.5 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.1 | 0.2 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.1 | 0.4 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 0.5 | GO:0002667 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.1 | 3.4 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
0.1 | 0.5 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.8 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.1 | 0.2 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.1 | 0.2 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.1 | 0.2 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.1 | 0.4 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.1 | 0.3 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.1 | 0.3 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.2 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.1 | 0.2 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.1 | 0.5 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.1 | 2.4 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.1 | 0.1 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 0.3 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.1 | 0.3 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.1 | 0.5 | GO:0001553 | luteinization(GO:0001553) |
0.1 | 0.4 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.1 | 0.1 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.1 | 0.7 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.1 | 0.2 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 0.2 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.1 | 0.1 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.1 | 0.2 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.1 | 0.2 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.1 | 0.3 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.1 | 0.2 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.1 | 0.2 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.1 | 0.2 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 0.2 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.1 | 0.1 | GO:0003164 | His-Purkinje system development(GO:0003164) |
0.1 | 0.4 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.4 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.1 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
0.1 | 0.5 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.1 | 0.1 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.1 | 0.1 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.1 | 0.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.1 | 0.1 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 0.4 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.1 | 0.7 | GO:0072538 | T-helper 17 type immune response(GO:0072538) |
0.1 | 0.1 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.1 | 0.4 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 0.5 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.2 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 0.1 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.1 | 0.2 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.1 | 0.1 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.1 | 0.2 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.1 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
0.1 | 0.3 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 0.1 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.1 | 0.6 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.1 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.1 | 0.2 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.1 | 0.1 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 0.1 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.1 | 0.1 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.1 | 1.1 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 0.3 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.1 | 0.1 | GO:0072050 | S-shaped body morphogenesis(GO:0072050) |
0.1 | 0.2 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.1 | 0.4 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.0 | 0.4 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 0.1 | GO:0071732 | cellular response to nitric oxide(GO:0071732) |
0.0 | 0.4 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.0 | 1.0 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
0.0 | 0.1 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.0 | 0.1 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.0 | 0.1 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.0 | 0.1 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.0 | 0.2 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
0.0 | 1.0 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.0 | 0.1 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.0 | 0.3 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 | 0.1 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.0 | 0.8 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.2 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.0 | 0.1 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.0 | 0.4 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.0 | 0.3 | GO:0006983 | ER overload response(GO:0006983) |
0.0 | 0.1 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.0 | 0.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 | 0.1 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.0 | 0.0 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.0 | 0.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 0.1 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.0 | 0.2 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.0 | 0.1 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.0 | 0.1 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.0 | 2.4 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.0 | 0.1 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.0 | 0.4 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.0 | 0.3 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.0 | 0.6 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.0 | 1.4 | GO:0009268 | response to pH(GO:0009268) |
0.0 | 3.7 | GO:0098792 | xenophagy(GO:0098792) |
0.0 | 0.0 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
0.0 | 0.3 | GO:0000467 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.0 | 0.8 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.0 | 0.0 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.0 | 0.1 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.0 | 0.1 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.0 | 0.4 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.0 | 0.2 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.0 | 0.1 | GO:0060618 | nipple development(GO:0060618) |
0.0 | 0.2 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.0 | 0.1 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.0 | 0.2 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.0 | 0.1 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.0 | 0.1 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.0 | 0.2 | GO:0031000 | response to caffeine(GO:0031000) |
0.0 | 0.3 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.0 | 0.1 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.0 | 0.1 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.0 | 0.1 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.0 | 0.0 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.0 | 0.1 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.0 | 0.0 | GO:0032906 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.0 | 0.2 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.0 | 0.1 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.1 | GO:0009838 | abscission(GO:0009838) |
0.0 | 0.2 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.0 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.1 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.0 | 0.0 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.0 | 0.1 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.0 | 0.1 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.0 | 0.2 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.0 | 0.1 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.0 | 0.2 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.0 | 0.1 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.0 | 0.2 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.0 | 0.2 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.0 | 0.2 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.0 | 0.1 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.0 | 0.2 | GO:0032252 | secretory granule localization(GO:0032252) |
0.0 | 0.1 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.0 | 0.1 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.0 | 0.1 | GO:0097461 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.0 | 0.2 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 0.7 | GO:0009303 | rRNA transcription(GO:0009303) |
0.0 | 0.4 | GO:0080111 | DNA demethylation(GO:0080111) |
0.0 | 0.6 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.2 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.0 | 0.1 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.0 | 0.2 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.0 | 0.1 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.0 | 0.4 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.0 | 0.2 | GO:0042637 | catagen(GO:0042637) |
0.0 | 0.1 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.0 | 0.1 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.0 | 0.2 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.0 | 0.5 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.0 | 0.6 | GO:0045214 | sarcomere organization(GO:0045214) |
0.0 | 0.4 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.0 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.0 | 0.2 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.0 | 0.1 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.0 | 0.2 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.0 | 0.0 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.0 | 0.1 | GO:0030070 | insulin processing(GO:0030070) |
0.0 | 0.1 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.0 | 0.1 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.0 | 0.0 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.0 | 0.1 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.0 | 0.0 | GO:0003213 | cardiac right atrium morphogenesis(GO:0003213) |
0.0 | 0.2 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
0.0 | 0.1 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.0 | 0.0 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.0 | 0.0 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.0 | 0.2 | GO:0060613 | fat pad development(GO:0060613) |
0.0 | 0.2 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 | 0.1 | GO:0006562 | proline catabolic process(GO:0006562) |
0.0 | 0.2 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.0 | 0.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.0 | 0.1 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
0.0 | 0.1 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.0 | 0.1 | GO:0007494 | midgut development(GO:0007494) |
0.0 | 0.4 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.0 | 0.1 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.0 | 0.2 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.0 | 0.1 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.0 | 0.1 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.0 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
0.0 | 0.1 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.0 | 0.1 | GO:0045345 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.0 | 0.2 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.0 | 0.1 | GO:0007097 | nuclear migration(GO:0007097) |
0.0 | 0.2 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.0 | 0.0 | GO:0034135 | regulation of toll-like receptor 2 signaling pathway(GO:0034135) negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
0.0 | 0.1 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.0 | 0.3 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.1 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.0 | 0.4 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.1 | GO:0019086 | late viral transcription(GO:0019086) |
0.0 | 0.1 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.0 | 0.1 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.0 | 0.1 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.0 | 0.2 | GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
0.0 | 0.3 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.0 | 0.0 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
0.0 | 0.0 | GO:1902966 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.0 | 0.1 | GO:0034633 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.0 | 0.2 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.0 | 0.4 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.0 | 0.1 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.0 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.0 | 0.1 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.0 | 0.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.2 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.0 | 0.0 | GO:0090269 | fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) |
0.0 | 0.1 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.0 | 0.1 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.0 | 0.0 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.0 | 0.2 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.0 | 0.5 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.0 | 0.1 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.0 | 0.1 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.0 | 0.1 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.0 | 0.1 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.0 | 0.1 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.0 | 0.1 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.0 | 0.0 | GO:0034238 | macrophage fusion(GO:0034238) |
0.0 | 0.0 | GO:0002730 | dendritic cell cytokine production(GO:0002371) regulation of dendritic cell cytokine production(GO:0002730) |
0.0 | 0.0 | GO:0003032 | detection of oxygen(GO:0003032) |
0.0 | 0.1 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.0 | 0.1 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.0 | 0.1 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.0 | 0.1 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.0 | 0.2 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.0 | 0.1 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.0 | 0.1 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 0.1 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.0 | 0.0 | GO:0075136 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.0 | 0.2 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.0 | 0.1 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.0 | 0.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.0 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.0 | 0.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.1 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.0 | 0.0 | GO:0033026 | negative regulation of mast cell apoptotic process(GO:0033026) mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.0 | 0.1 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.0 | 0.1 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.0 | 0.4 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.0 | 0.2 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.0 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.0 | 0.6 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 0.1 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.1 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.0 | 0.2 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.0 | 0.1 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.0 | 0.1 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.0 | 0.0 | GO:0042706 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.0 | 0.2 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.1 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.0 | 0.2 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.0 | 0.0 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
0.0 | 0.1 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.0 | 2.2 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.0 | 0.0 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.0 | 0.1 | GO:0007296 | vitellogenesis(GO:0007296) |
0.0 | 0.1 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) |
0.0 | 0.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.6 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.0 | 0.2 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.0 | 0.1 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.0 | 0.5 | GO:0010761 | fibroblast migration(GO:0010761) |
0.0 | 0.1 | GO:0060544 | regulation of necroptotic process(GO:0060544) |
0.0 | 0.1 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.0 | 0.1 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.0 | 0.2 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.0 | 0.2 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.0 | 0.1 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.0 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.0 | 0.1 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.0 | 0.1 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.0 | 0.1 | GO:0015671 | oxygen transport(GO:0015671) |
0.0 | 0.2 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.0 | 0.2 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.0 | 0.2 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.0 | 0.1 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.0 | 0.0 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.0 | 0.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.0 | 0.2 | GO:0032459 | regulation of protein oligomerization(GO:0032459) |
0.0 | 0.1 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.0 | 0.1 | GO:0003383 | apical constriction(GO:0003383) |
0.0 | 0.0 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) |
0.0 | 0.1 | GO:0090009 | primitive streak formation(GO:0090009) |
0.0 | 0.1 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.0 | 0.0 | GO:0021564 | vagus nerve development(GO:0021564) |
0.0 | 0.5 | GO:0046902 | regulation of mitochondrial membrane permeability(GO:0046902) |
0.0 | 0.0 | GO:0044805 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
0.0 | 0.0 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.0 | 0.6 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.4 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.0 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.0 | 0.0 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.0 | 0.0 | GO:1902896 | terminal web assembly(GO:1902896) |
0.0 | 0.1 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.1 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.0 | 0.1 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.1 | GO:0009174 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.0 | 0.0 | GO:0070305 | response to cGMP(GO:0070305) |
0.0 | 0.1 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.0 | 0.2 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.0 | 0.1 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.0 | 0.1 | GO:0048340 | paraxial mesoderm morphogenesis(GO:0048340) paraxial mesoderm formation(GO:0048341) |
0.0 | 0.0 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.0 | 0.0 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.0 | 0.0 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.0 | 0.2 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.0 | 0.4 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.0 | 0.0 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.0 | 0.1 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.0 | 0.2 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.0 | 0.0 | GO:0038084 | vascular endothelial growth factor signaling pathway(GO:0038084) |
0.0 | 0.5 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.0 | 0.1 | GO:0003198 | epithelial to mesenchymal transition involved in endocardial cushion formation(GO:0003198) |
0.0 | 0.1 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.0 | 0.0 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.0 | 0.0 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) regulation of locomotion involved in locomotory behavior(GO:0090325) |
0.0 | 0.1 | GO:0006742 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
0.0 | 0.9 | GO:0030193 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
0.0 | 0.1 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.0 | 0.0 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.0 | 0.1 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.0 | 0.0 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
0.0 | 0.2 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.0 | 0.5 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.1 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.0 | 0.0 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.0 | 0.1 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.0 | 0.3 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.2 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.0 | 0.1 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 0.1 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.0 | 0.0 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.0 | 0.1 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.0 | 0.0 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.0 | 0.1 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
0.0 | 0.0 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 0.1 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.0 | 0.1 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.0 | 0.1 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.0 | 0.0 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.0 | 0.1 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.0 | 0.1 | GO:0097012 | response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.0 | 0.0 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.0 | 0.0 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.0 | 0.0 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.0 | 1.2 | GO:0031398 | positive regulation of protein ubiquitination(GO:0031398) |
0.0 | 0.0 | GO:0031269 | pseudopodium assembly(GO:0031269) |
0.0 | 0.0 | GO:0042148 | strand invasion(GO:0042148) |
0.0 | 0.2 | GO:0006525 | arginine metabolic process(GO:0006525) |
0.0 | 0.2 | GO:0034340 | response to type I interferon(GO:0034340) |
0.0 | 0.1 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.0 | 0.1 | GO:0032275 | luteinizing hormone secretion(GO:0032275) |
0.0 | 0.2 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.0 | 0.1 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.0 | 0.1 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.0 | 0.0 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.0 | 0.1 | GO:0044247 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.0 | 0.0 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.0 | 0.1 | GO:0090042 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.0 | 0.0 | GO:0008354 | germ cell migration(GO:0008354) |
0.0 | 0.1 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.0 | 0.1 | GO:0033622 | integrin activation(GO:0033622) |
0.0 | 0.3 | GO:0017144 | drug metabolic process(GO:0017144) |
0.0 | 0.1 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.0 | 0.0 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.0 | 0.1 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.0 | 0.0 | GO:0060459 | left lung development(GO:0060459) |
0.0 | 0.0 | GO:0046083 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.0 | 0.0 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.0 | 0.0 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.0 | 0.1 | GO:0002931 | response to ischemia(GO:0002931) |
0.0 | 0.0 | GO:1902990 | telomere maintenance via semi-conservative replication(GO:0032201) mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.0 | 0.1 | GO:1904376 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.0 | 0.0 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.0 | 0.0 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.0 | 0.0 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.0 | 0.0 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.0 | 0.0 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.0 | 0.2 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.0 | 0.0 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.0 | 0.0 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.0 | 0.0 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.0 | 0.0 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.0 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.0 | 0.3 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.0 | 0.2 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 0.1 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.1 | GO:1904353 | regulation of telomere capping(GO:1904353) |
0.0 | 0.2 | GO:0006301 | postreplication repair(GO:0006301) |
0.0 | 0.0 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.0 | 0.0 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.0 | 0.0 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.0 | 0.0 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.0 | 0.0 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
0.0 | 0.0 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.0 | 0.0 | GO:0009757 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.0 | 0.0 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
0.0 | 0.1 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.0 | 0.0 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.0 | 0.0 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.0 | 0.3 | GO:0090662 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.1 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.0 | 0.1 | GO:0051818 | disruption of cells of other organism involved in symbiotic interaction(GO:0051818) killing of cells in other organism involved in symbiotic interaction(GO:0051883) |
0.0 | 0.1 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.0 | 0.0 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.0 | 0.3 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 1.2 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.0 | 0.1 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.0 | 0.1 | GO:0031297 | replication fork processing(GO:0031297) |
0.0 | 0.1 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.0 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.0 | 0.0 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.0 | 0.3 | GO:0006284 | base-excision repair(GO:0006284) |
0.0 | 0.0 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.0 | 0.1 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.0 | 0.1 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.0 | 0.0 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 0.3 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.0 | 0.0 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.0 | 0.0 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.0 | 0.1 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.0 | 0.0 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.0 | 0.0 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.0 | 0.1 | GO:0010573 | vascular endothelial growth factor production(GO:0010573) |
0.0 | 0.0 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.0 | 0.0 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.0 | 0.1 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.0 | 0.0 | GO:0061724 | lipophagy(GO:0061724) |
0.0 | 0.1 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.0 | 0.1 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.0 | 0.0 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.0 | 0.2 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.0 | 0.1 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.2 | GO:0070527 | platelet aggregation(GO:0070527) |
0.0 | 0.0 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.0 | 0.1 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.0 | 0.0 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.0 | 0.1 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.0 | 0.1 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.0 | 0.1 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.0 | 0.0 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.0 | 0.0 | GO:0009111 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.0 | 0.0 | GO:0034350 | regulation of glial cell apoptotic process(GO:0034350) |
0.0 | 0.1 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.1 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.1 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.0 | 0.1 | GO:0016102 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) terpenoid biosynthetic process(GO:0016114) |
0.0 | 0.1 | GO:0009086 | methionine biosynthetic process(GO:0009086) |
0.0 | 0.0 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.0 | 0.0 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.0 | 0.0 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.0 | 0.0 | GO:0045713 | low-density lipoprotein particle receptor biosynthetic process(GO:0045713) regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.0 | 0.0 | GO:0034349 | glial cell apoptotic process(GO:0034349) |
0.0 | 0.0 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.0 | 0.1 | GO:0030903 | notochord development(GO:0030903) |
0.0 | 0.0 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.0 | 0.0 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.0 | 0.0 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.0 | 0.0 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.0 | 0.0 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.0 | 0.1 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.0 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.0 | 0.1 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
0.0 | 0.1 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.0 | 0.1 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.0 | 0.1 | GO:0070633 | transepithelial transport(GO:0070633) |
0.0 | 0.1 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.0 | 0.0 | GO:0045822 | negative regulation of heart contraction(GO:0045822) |
0.0 | 0.0 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.0 | 0.4 | GO:0003073 | regulation of systemic arterial blood pressure(GO:0003073) |
0.0 | 0.0 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.0 | 0.0 | GO:0036120 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.0 | 0.0 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.0 | 0.0 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.0 | 0.0 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.0 | 0.0 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.0 | 0.1 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.0 | 0.0 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.0 | 0.0 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.0 | 0.0 | GO:0045823 | positive regulation of heart contraction(GO:0045823) |
0.0 | 0.1 | GO:1901185 | negative regulation of ERBB signaling pathway(GO:1901185) |
0.0 | 0.0 | GO:0031639 | plasminogen activation(GO:0031639) |
0.0 | 0.1 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.0 | 0.0 | GO:0060547 | negative regulation of necrotic cell death(GO:0060547) |
0.0 | 0.1 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.0 | 0.1 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.0 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.0 | 0.1 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.1 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.0 | 0.0 | GO:0009597 | detection of virus(GO:0009597) |
0.0 | 0.0 | GO:0045914 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
0.0 | 0.0 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.0 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.0 | 0.0 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.0 | 0.0 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.0 | 0.1 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.0 | 0.0 | GO:0030242 | pexophagy(GO:0030242) |
0.0 | 0.0 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.0 | 0.0 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.0 | GO:1904667 | regulation of ubiquitin protein ligase activity(GO:1904666) negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.0 | 0.0 | GO:0007144 | female meiosis I(GO:0007144) |
0.0 | 0.0 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 4.7 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
1.4 | 4.1 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.8 | 6.9 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.7 | 9.6 | GO:0031430 | M band(GO:0031430) |
0.5 | 2.5 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.4 | 2.2 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.4 | 0.7 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.3 | 4.3 | GO:0005916 | fascia adherens(GO:0005916) |
0.3 | 1.0 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.3 | 2.0 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.3 | 0.9 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.3 | 0.9 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.3 | 4.4 | GO:0043034 | costamere(GO:0043034) |
0.3 | 4.1 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.3 | 0.8 | GO:0097443 | sorting endosome(GO:0097443) |
0.3 | 4.3 | GO:0097440 | apical dendrite(GO:0097440) |
0.3 | 0.8 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.3 | 12.5 | GO:0016459 | myosin complex(GO:0016459) |
0.2 | 5.0 | GO:0036379 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
0.2 | 7.7 | GO:0014704 | intercalated disc(GO:0014704) |
0.2 | 2.0 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 0.5 | GO:0097427 | microtubule bundle(GO:0097427) |
0.2 | 0.3 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 0.4 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 7.5 | GO:0030018 | Z disc(GO:0030018) |
0.1 | 1.3 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 0.8 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 2.5 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 0.4 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.1 | 2.1 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.1 | 0.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.5 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 1.0 | GO:0031674 | I band(GO:0031674) |
0.1 | 0.7 | GO:0031983 | vesicle lumen(GO:0031983) |
0.1 | 0.5 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 2.0 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 3.0 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 0.3 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 0.3 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 2.5 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 1.5 | GO:0030017 | sarcomere(GO:0030017) |
0.1 | 5.1 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 0.4 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 0.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 1.1 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 0.6 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.5 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 0.1 | GO:0031523 | Myb complex(GO:0031523) |
0.1 | 0.4 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 2.0 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 1.8 | GO:0008305 | integrin complex(GO:0008305) |
0.1 | 0.4 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 0.2 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 0.2 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.1 | 0.1 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.1 | 0.2 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 0.7 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.0 | 0.4 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.0 | 0.7 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.0 | 1.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.1 | GO:1990357 | terminal web(GO:1990357) |
0.0 | 0.4 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.1 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.0 | 1.2 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 0.4 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 0.1 | GO:0097413 | Lewy body(GO:0097413) |
0.0 | 0.2 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 1.0 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.5 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 0.2 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 2.1 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.5 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 0.2 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.0 | 0.2 | GO:0033263 | CORVET complex(GO:0033263) |
0.0 | 0.2 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.0 | 0.4 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 0.2 | GO:0071439 | clathrin complex(GO:0071439) |
0.0 | 0.1 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.0 | 0.2 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.2 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 0.1 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.0 | 0.3 | GO:0030016 | myofibril(GO:0030016) |
0.0 | 0.2 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.0 | 0.3 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 0.1 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.0 | 0.1 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.0 | 0.0 | GO:1990745 | EARP complex(GO:1990745) |
0.0 | 0.2 | GO:0043203 | axon hillock(GO:0043203) |
0.0 | 0.4 | GO:0097228 | sperm principal piece(GO:0097228) |
0.0 | 0.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.0 | 0.1 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.0 | 0.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.0 | 0.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.1 | GO:0035363 | histone locus body(GO:0035363) |
0.0 | 0.1 | GO:0000938 | GARP complex(GO:0000938) |
0.0 | 0.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 0.8 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 0.1 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.0 | 0.1 | GO:0055087 | Ski complex(GO:0055087) |
0.0 | 1.5 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 0.2 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 0.0 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.0 | 0.1 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.0 | 0.0 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.0 | 0.2 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.1 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.0 | 0.3 | GO:0000800 | lateral element(GO:0000800) |
0.0 | 0.1 | GO:0061617 | MICOS complex(GO:0061617) |
0.0 | 0.2 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 0.1 | GO:0097470 | ribbon synapse(GO:0097470) |
0.0 | 0.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.3 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.1 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.0 | 0.1 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.0 | 0.1 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.0 | 0.2 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.1 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.0 | 0.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.3 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.0 | 0.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.1 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.0 | 0.2 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.3 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 3.1 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.0 | 1.2 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.0 | 0.2 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.0 | 0.1 | GO:0035838 | growing cell tip(GO:0035838) |
0.0 | 0.1 | GO:0044308 | axonal spine(GO:0044308) |
0.0 | 0.2 | GO:0097542 | ciliary tip(GO:0097542) |
0.0 | 0.4 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.1 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.0 | 0.1 | GO:0072687 | meiotic spindle(GO:0072687) |
0.0 | 0.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.1 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.0 | 0.7 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.0 | 0.1 | GO:0097255 | R2TP complex(GO:0097255) |
0.0 | 0.0 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.0 | 0.1 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.0 | 0.7 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.1 | GO:0045179 | apical cortex(GO:0045179) |
0.0 | 0.0 | GO:1990423 | RZZ complex(GO:1990423) |
0.0 | 0.1 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.0 | 0.1 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.2 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.0 | GO:0043511 | inhibin complex(GO:0043511) |
0.0 | 0.0 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
0.0 | 0.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.0 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.0 | 0.1 | GO:0090543 | Flemming body(GO:0090543) |
0.0 | 0.0 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.0 | 0.1 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.0 | 0.0 | GO:0044449 | contractile fiber part(GO:0044449) |
0.0 | 0.1 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.0 | 0.1 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.0 | 0.6 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.0 | 0.1 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.0 | 0.0 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.0 | 0.1 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 0.1 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.0 | 0.0 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 0.1 | GO:0001527 | microfibril(GO:0001527) |
0.0 | 0.4 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.0 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.3 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 0.1 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.0 | 0.8 | GO:0005581 | collagen trimer(GO:0005581) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 4.4 | GO:0031013 | troponin I binding(GO:0031013) |
0.9 | 3.5 | GO:0031433 | telethonin binding(GO:0031433) |
0.8 | 4.2 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.8 | 2.3 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.6 | 4.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.6 | 1.7 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.5 | 1.5 | GO:0051373 | FATZ binding(GO:0051373) |
0.5 | 1.4 | GO:0070538 | oleic acid binding(GO:0070538) |
0.5 | 4.5 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.4 | 2.0 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.3 | 1.0 | GO:0055100 | adiponectin binding(GO:0055100) |
0.3 | 6.9 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.3 | 0.7 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.3 | 1.0 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.3 | 2.8 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.3 | 1.3 | GO:0043426 | MRF binding(GO:0043426) |
0.3 | 0.8 | GO:0051425 | PTB domain binding(GO:0051425) |
0.2 | 0.7 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.2 | 1.7 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.2 | 4.4 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 2.6 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.2 | 0.6 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.2 | 1.2 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.2 | 3.1 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 1.0 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.2 | 0.6 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.2 | 2.6 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.2 | 1.1 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.2 | 9.8 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.2 | 0.9 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 1.6 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.2 | 0.5 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.2 | 0.5 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.2 | 1.2 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.2 | 1.5 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.2 | 0.5 | GO:0008142 | oxysterol binding(GO:0008142) |
0.2 | 0.5 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.2 | 1.0 | GO:0031432 | titin binding(GO:0031432) |
0.2 | 0.5 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.2 | 1.1 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.2 | 0.2 | GO:0030172 | troponin C binding(GO:0030172) |
0.2 | 2.1 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 5.2 | GO:0043531 | ADP binding(GO:0043531) |
0.1 | 0.7 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 0.6 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.1 | 3.2 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 0.3 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.1 | 1.6 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 0.7 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.1 | 0.7 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 0.4 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.1 | 2.9 | GO:0004119 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.1 | 0.8 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 1.3 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.8 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.1 | 0.3 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 1.2 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.2 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.1 | 0.3 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.1 | 0.8 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.1 | 0.7 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.1 | 0.1 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.1 | 0.5 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.1 | 0.4 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 0.3 | GO:0035939 | microsatellite binding(GO:0035939) |
0.1 | 0.4 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 0.4 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.2 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.1 | 0.4 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.1 | 0.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.3 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.1 | 1.7 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.4 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 0.9 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.1 | 0.5 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 0.2 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 0.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.3 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.4 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 0.3 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.1 | 0.5 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 1.0 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.1 | 0.3 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 0.3 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.1 | 4.2 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 4.1 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 0.3 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.1 | 0.7 | GO:0008143 | poly(A) binding(GO:0008143) |
0.1 | 0.4 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.1 | 0.2 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.2 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.1 | 0.6 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 2.3 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.1 | 0.2 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.1 | 1.5 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.2 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 0.2 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.1 | 0.2 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.1 | 0.3 | GO:0002054 | nucleobase binding(GO:0002054) |
0.1 | 4.6 | GO:0005496 | steroid binding(GO:0005496) |
0.1 | 0.2 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.0 | 0.6 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.3 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.0 | 0.3 | GO:0000182 | rDNA binding(GO:0000182) |
0.0 | 0.7 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 1.6 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 0.4 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.1 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.1 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.0 | 0.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.7 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.2 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 3.9 | GO:0044325 | ion channel binding(GO:0044325) |
0.0 | 0.9 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.3 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.0 | 0.2 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.0 | 0.5 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.2 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.0 | 0.3 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.0 | 0.8 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.0 | 0.4 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.0 | 0.1 | GO:0035276 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) ethanol binding(GO:0035276) |
0.0 | 0.0 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.0 | 0.7 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.4 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.1 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.0 | 0.2 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.0 | 0.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.1 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.0 | 0.4 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
0.0 | 0.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.2 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.0 | 0.9 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.2 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.0 | 0.2 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) |
0.0 | 0.1 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.0 | 0.2 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.0 | 0.2 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.0 | 0.1 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.0 | 0.2 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 0.1 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.0 | 0.8 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 0.7 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.1 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.0 | 0.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.0 | 0.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.2 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.1 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.0 | 0.3 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 0.2 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.0 | 3.4 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 0.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.0 | 0.3 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 0.3 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.0 | 0.1 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.0 | 0.0 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.0 | 0.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.2 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.0 | 0.1 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.0 | 0.1 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.0 | 0.0 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.0 | 0.1 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.2 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.0 | 0.0 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.0 | 0.2 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.0 | 0.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.0 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.0 | 0.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.4 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.0 | 1.8 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.1 | GO:0030984 | kininogen binding(GO:0030984) |
0.0 | 0.3 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.0 | 1.7 | GO:0043765 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.0 | 0.3 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.1 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.0 | 0.2 | GO:0000150 | recombinase activity(GO:0000150) |
0.0 | 0.2 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.2 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.0 | 0.0 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.0 | 0.2 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 0.0 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.0 | 1.0 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.1 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.0 | 0.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.0 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.0 | 0.1 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.0 | 0.1 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.0 | 0.1 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.0 | 0.1 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 0.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.0 | 0.2 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.3 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.0 | 0.2 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.0 | 0.1 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.0 | 0.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 1.9 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.0 | 0.8 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.0 | GO:0030911 | TPR domain binding(GO:0030911) |
0.0 | 0.1 | GO:0008199 | ferric iron binding(GO:0008199) |
0.0 | 0.1 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.0 | 0.0 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.0 | 0.2 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 0.1 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.0 | 0.0 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.0 | 0.3 | GO:0008418 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
0.0 | 0.1 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.0 | 0.1 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.0 | 0.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 0.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 0.1 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.0 | 0.2 | GO:0034901 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.0 | 0.0 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.0 | 0.3 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.1 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.0 | 0.2 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.0 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.0 | 0.1 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.0 | 0.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.0 | 0.0 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
0.0 | 0.2 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.6 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 0.1 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.0 | 0.1 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.2 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.0 | GO:0019961 | interferon binding(GO:0019961) |
0.0 | 0.4 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.2 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.1 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.0 | 0.1 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.0 | 0.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 3.1 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 0.2 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.1 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.0 | 0.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.0 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.2 | GO:0045502 | dynein binding(GO:0045502) |
0.0 | 0.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.0 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.0 | 0.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 0.0 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.0 | 0.0 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.0 | 0.1 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.0 | 0.4 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.3 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.0 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.0 | 0.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.1 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.0 | 0.2 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.1 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 0.0 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.0 | 0.1 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.0 | 0.0 | GO:0030519 | snoRNP binding(GO:0030519) |
0.0 | 0.1 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.0 | 0.2 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.0 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.1 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.0 | 0.1 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.0 | 0.0 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.0 | 0.1 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.0 | 0.1 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 1.0 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.0 | 0.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.4 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.1 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.0 | 0.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.0 | 0.0 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.0 | 0.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.0 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.0 | 0.9 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.2 | GO:0000252 | C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity(GO:0000252) mevaldate reductase activity(GO:0004495) gluconate dehydrogenase activity(GO:0008875) epoxide dehydrogenase activity(GO:0018451) 5-exo-hydroxycamphor dehydrogenase activity(GO:0018452) 2-hydroxytetrahydrofuran dehydrogenase activity(GO:0018453) acetoin dehydrogenase activity(GO:0019152) phenylcoumaran benzylic ether reductase activity(GO:0032442) D-xylose:NADP reductase activity(GO:0032866) L-arabinose:NADP reductase activity(GO:0032867) D-arabinitol dehydrogenase, D-ribulose forming (NADP+) activity(GO:0033709) (R)-(-)-1,2,3,4-tetrahydronaphthol dehydrogenase activity(GO:0034831) 3-hydroxymenthone dehydrogenase activity(GO:0034840) very long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0035380) dihydrotestosterone 17-beta-dehydrogenase activity(GO:0035410) (R)-2-hydroxyisocaproate dehydrogenase activity(GO:0043713) L-arabinose 1-dehydrogenase (NADP+) activity(GO:0044103) L-xylulose reductase (NAD+) activity(GO:0044105) 3-ketoglucose-reductase activity(GO:0048258) D-arabinitol dehydrogenase, D-xylulose forming (NADP+) activity(GO:0052677) |
0.0 | 0.1 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 0.0 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.0 | 0.0 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.0 | 0.1 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 0.0 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.0 | 0.1 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.0 | 0.1 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.0 | 0.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.0 | GO:0019002 | GMP binding(GO:0019002) |
0.0 | 0.4 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.1 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.0 | 0.4 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.2 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.0 | 0.0 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
0.0 | 0.0 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.0 | 0.2 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.0 | 0.1 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.0 | 0.2 | GO:0022841 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.0 | 0.5 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.0 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.0 | 0.0 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.0 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.0 | 0.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.1 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.0 | 0.1 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.0 | 0.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.0 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.0 | 0.0 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.1 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.1 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.1 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
0.0 | 0.1 | GO:0019841 | retinol binding(GO:0019841) |
0.0 | 0.0 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.0 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.0 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 0.2 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.0 | 0.1 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.0 | 0.1 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.0 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.0 | 0.1 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.0 | GO:0035877 | death effector domain binding(GO:0035877) |
0.0 | 0.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.0 | 0.0 | GO:0005350 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.0 | 0.0 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.0 | 0.0 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 5.1 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 6.5 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 1.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 1.0 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 5.8 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 4.7 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 1.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 1.2 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 2.5 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 3.1 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 0.9 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 1.0 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 0.7 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 3.6 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 1.8 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 2.8 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 1.2 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 2.2 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 2.4 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 0.7 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 0.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.7 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.4 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 2.1 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 1.3 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.2 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.0 | 0.5 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.4 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 1.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.2 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.0 | 1.0 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.2 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 0.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.2 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 0.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.1 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 1.0 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 0.1 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.8 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.7 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.4 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.4 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.2 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 0.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.3 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.2 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.3 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.2 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.4 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.4 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 2.1 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.0 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.2 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.0 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.0 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.1 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.3 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.2 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 9.7 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.3 | 6.0 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.3 | 4.5 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.2 | 6.1 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 3.6 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 1.9 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 2.2 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 4.7 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 1.0 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 2.2 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 0.2 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 0.9 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 0.3 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.1 | 3.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 0.8 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 0.3 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 0.7 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 0.2 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.1 | 0.5 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 0.8 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 0.4 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 0.6 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 0.4 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.1 | 0.7 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 5.9 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 1.2 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.4 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.6 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.2 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.2 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.0 | 0.4 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.7 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.7 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 0.4 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.0 | 1.1 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.7 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.3 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.0 | 0.3 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.0 | 0.3 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.0 | 0.4 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 3.3 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 2.6 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.3 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 0.4 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 0.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.4 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.5 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.9 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 1.5 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.4 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.4 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 0.2 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.0 | 0.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.8 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.2 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.5 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.0 | 0.4 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.0 | 0.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.6 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.3 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.3 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.1 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 0.3 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.2 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 1.6 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 1.0 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.0 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.0 | 4.0 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.5 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.1 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.6 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.2 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.0 | 0.2 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.1 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.0 | 0.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.3 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 0.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.1 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.4 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.7 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.2 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.0 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.0 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.2 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.0 | 0.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.0 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.0 | 0.1 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.2 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.2 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.0 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
0.0 | 0.3 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 0.4 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.0 | 0.2 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.0 | 0.1 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.0 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.1 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.1 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.0 | 0.0 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.0 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.1 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.0 | 0.1 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.1 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |